## Core Concept
Zollinger-Ellison syndrome is a condition characterized by excessive gastric acid production due to high levels of gastrin, often caused by a gastrinoma. Effective management involves reducing gastric acid secretion.

## Why the Correct Answer is Right
The correct answer, **Omeprazole**, is a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells. This mechanism is particularly useful in conditions like Zollinger-Ellison syndrome, where there is a need to significantly decrease acid production.

## Why Each Wrong Option is Incorrect
* **Option A: Ranitidine** - This is an H2 receptor antagonist, which is less potent than PPIs in reducing acid secretion and may not adequately control symptoms in Zollinger-Ellison syndrome.
* **Option B: Sucralfate** - This works by forming a protective barrier over ulcers, promoting healing, but does not address the underlying issue of excessive acid production.
* **Option D: Misoprostol** - This is a prostaglandin E1 analogue that reduces acid secretion but is typically used for gastroprotection in patients taking NSAIDs and is not the first-line treatment for Zollinger-Ellison syndrome.

## Clinical Pearl / High-Yield Fact
A key point to remember is that in Zollinger-Ellison syndrome, **proton pump inhibitors (PPIs) are the mainstay of treatment** because they can effectively control acid hypersecretion. Also, note that the diagnosis and management of Zollinger-Ellison syndrome often involve confirming the presence of a gastrinoma and considering surgical options.

## Correct Answer: C. Omeprazole